Odyssey Health, Inc.
ODYY· OTC
ODYYOdyssey Health, Inc.
Filed Mar 22, 2024 · 10-Q · 51 days after period end · 0001683168-24-001645
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | $13.28M | -$1.67M | -$1.69M | -$869.30K |
| EPS Diluted | $0.12 | -$0.02 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Jan 31, 2024 · filed Mar 22, 2024 · 51 d after period end
